Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | FDPS | P14324 | 15/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6307341 | 0.89 | FDPS (0.45) | LMNAFDPSGGPS1LPAR1LPAR3 | |
| SCHEMBL385677 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL1238007 | 0.79 | FDPS (0.37) | LMNAFDPSGGPS1LPAR1LPAR3 | |
| SCHEMBL10965541 | 0.78 | ACHE (0.42) | LMNALPAR1LPAR3 | |
| SCHEMBL9459028 | 0.77 | CASP1 (0.31) | — | |
| SCHEMBL29155304 | 0.77 | FDPS (0.36) | LMNAFDPSGGPS1LAP3LPAR1 | |
| SCHEMBL11151927 | 0.75 | FDPS (0.34) | LMNAFDPSGGPS1LAP3 | |
| SCHEMBL27783191 | 0.75 | FDPS (0.40) | LMNAFDPSGGPS1LAP3 | |
| SCHEMBL9231254 | 0.73 | — | — | |
| SCHEMBL513412 | 0.70 | FDPS (0.31) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 648 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118406363-A | Graphene oxide-fiber hybrid material reinforced phthalene biphenyl polyarylether resin-based composite material and preparation method thereof | 大连理工大学 | 2024-07-30 | — | — | CN | claimed |
| EP-2719689-B1 | Novel method for synthesising 3-(2-bromo-4,5-dimethoxyphenyl) propanenitrile and use for synthesising ivabradine and the added salts thereof with a pharmaceutically acceptable acid | SERVIER LAB (FR) | 2015-12-23 | — | — | EP | claimed |
| WO-2014057228-A1 | NEW METHOD FOR SYNTHESISING -(2-BROMO-4,5-DIMETHOXYPHENYL)PROPANENITRILE, AND APPLICATION TO THE SYNTHESIS OF IVABRADINE AND THE ADDITION SALTS OF SAME WITH A PHARMACEUTICALLY ACCEPTABLE ACID | LES LABORATOIRES SERVIER (FR) | 2014-04-17 | — | — | WO | claimed |
| EP-2719689-A1 | Novel method for synthesising 3-(2-bromo-4,5-dimethoxyphenyl) propanenitrile and use for synthesising ivabradine and the added salts thereof with a pharmaceutically acceptable acid | Les Laboratoires Servier (FR) | 2014-04-16 | — | — | EP | claimed |
| US-20080280934-A1 | Method of Preparing Porphyrin Derivatives, Porphyrin Derivatives, Uses Thereof and Pharmaceutical Compositions | SPECTRACURE AB (SE) | 2008-11-13 | — | — | US | claimed |
| EP-1709048-A2 | METHOD OF PREPARING PORPHYRIN DERIVATIVES, PORPHYRIN DERIVATIVES, USES THEREOF AND PHARMACEUTICAL COMPOSITIONS | Photobiochem N.V. (NL) | 2006-10-11 | — | — | EP | claimed |
| EP-1099694-B1 | PROCESS FOR THE PREPARATION OF QUINOLINE DERIVATIVE AND INTERMEDIATE THEREFOR | NISSAN CHEMICAL IND LTD (JP) | 2005-08-17 | — | — | EP | claimed |
| WO-2005058909-A2 | METHOD OF PREPARING PORPHYRIN DERIVATIVES, PORPHYRIN DERIVATIVES, USES THEREOF AND PHARMACEUTICAL COMPOSITIONS | PHOTOBIOCHEM N.V. (NL) | 2005-06-30 | — | — | WO | claimed |
| EP-0260305-B1 | QUINOLINYL ETHER TETRAZOLE AS AGENT FOR THE TREATMENT OF HYPERSENSITIVE AILMENTS | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-12-16 | — | — | EP | claimed |
| JP-1079157-A | — | — | None | — | — | JP | disclosed |
| US-12583818-B2 | Compound, preparation method thereof, and use thereof | DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (KR) | 2026-03-24 | — | — | US | disclosed |
| EP-4683912-A1 | SUBSTITUTED THIOPHENE FUSED CYCLOHEXANONE DERIVATIVES, COMPOSITIONS COMPRISING THE SAME AND THEIR USE AS PHARMACEUTICALS | Neurasic Therapeutics Inc. (CA) | 2026-01-28 | — | — | EP | disclosed |
| US-20260008757-A1 | N-(3-(AMINOMETHYL)-PHENYL)-5-(4-PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES | BASF SE (DE) | 2026-01-08 | — | — | US | disclosed |
| US-20250368654-A1 | HETEROCYCLIC INHIBITORS OF ENPP1 | VOLASTRA THERAPEUTICS, INC. (US) | 2025-12-04 | — | — | US | disclosed |
| US-4188396-A | ANTIDEPRESSANTS | CIBA-GEIGY CORPORATION (US) | 1980-02-12 | — | — | US | disclosed |
| US-4169108-A | 5(OR 6)-[(Substituted-amino)alkyl]-2,3-naphthalenediols | STERLING DRUG INC. (US) | 1979-09-25 | — | — | US | disclosed |
| US-4011336-A | ANTIPHLOGISTIC AGENTS | BASF AKTIENGESELLSCHAFT (DT) | 1977-03-08 | — | — | US | disclosed |
| US-3983243-A | INSECTICIDES | HOFFMANN-LA ROCHE INC. (US) | 1976-09-28 | — | — | US | disclosed |
| US-3949074-A | Cardiotonic pharmaceutical compositions containing a cardiac glycoside and method of use | BOEHRINGER INGELHEIM GMBH (DT) | 1976-04-06 | — | — | US | disclosed |
| US-3937711-A | POLYMERIC STABILIZERS, POLYOLEFINS | CIBA-GEIGY CORPORATION (US) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583818-B2 | Compound, preparation method thereof, and use thereof | TYRO3, TH, SRMS | LMNA 4025/4885FDPS 4375/4885GGPS1 4051/4885 |
| US-20260008757-A1 | N-(3-(AMINOMETHYL)-PHENYL)-5-(4-PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES | HCN1, HCN3, HTR3C | LMNA 833/4885FDPS 3608/4885GGPS1 3192/4885 |
| US-20250368654-A1 | HETEROCYCLIC INHIBITORS OF ENPP1 | ENPP1, ENPP3, ENPP2 | LMNA 3733/4885FDPS 104/4885GGPS1 40/4885 |
| US-20080280934-A1 | Method of Preparing Porphyrin Derivatives, Porphyrin Derivatives, Uses Thereof and Pharmaceutical Compositions | PANK2, PPOX, MVD | LMNA 2997/4885FDPS 432/4885GGPS1 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.